Prof. Christoph U. Correll

Christoph U. Correll is Professor of Psychiatry at The Zucker School of Medicine at Hofstra/Northwell, New York, USA, and also Professor and Chair of the Department of Child and Adolescent Psychiatry, Charité University Medicine, Berlin, Germany. He completed his medical studies at the Free University of Berlin in Germany, and Dundee University Medical School in Scotland. He is board certified in general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York. Since 1997, he has been working and conducting research in New York, USA, and since 2017 he is also working in Germany again.

Professor Correll focuses on the identification and treatment of youth and adults with severe mental illness, including schizophrenia, mood disorders, aggression-spectrum disorders and eating disorders, clinical trials, epidemiology, psychopharmacology, meta-analyses, and the interface between physical health and mental health.

He has authored or co-authored over 900 journal articles that have been cited more than 82.000 times and received over 40 research awards for his work. In October 2024, his h-index was 146 in Google Scholar, with an h-index >100 in the last 5 years alone.

Since 2014, he has been listed annually by Clarivate/Web of Science as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”.

https://publons.com/researcher/2796036/christoph-u-correll/

Additionally, he has been holding numerous Expertscape rankings based on the number of publications and citations in the past 10 years, i.e., for 15 topics as “Expert” (among the top 1% cited scientists), and 24 topics as “World Expert” (among the top 0.1% cited scientists), including in September 2024 ranked as number one among world experts for the following areas:

1. Central nervous system agents, out of 308,311 scientists (https://expertscape.com/ex/central+nervous+system+agents)
2. Psychotropic drugs, out of 131,808 scientists (https://expertscape.com/ex/psychotropic+drugs)
3. Schizophrenia Spectrum and Other Psychotic Disorders, out of 94,268 scientists (https://expertscape.com/ex/schizophrenia+spectrum+and+other+psychotic+disorders)
4. Schizophrenia, out of 90,874 scientists (https://expertscape.com/ex/schizophrenia)
5. Tranquilizing agents, out of 71,122 scientists (https://expertscape.com/ex/tranquilizing agents)
6. Weight gain, out of 68,578 scientists (https://expertscape.com/ex/weight+gain)
7. Delayed-action preparations out of 68,517 ranked scientists (https://expertscape.com/ex/delayed-action+preparations)
8. Antipsychotics, out of 60,313 scientists (https://expertscape.com/ex/antipsychotics)

Adolescence represents a uniquely vulnerable developmental window characterized by rapid biological maturation, profound psychosocial change, and heightened stress sensitivity. During adolescence, emotional regulation systems are still maturing while cognitive, social, and identity-related demands intensify, creating a mismatch between rising expectations and limited regulatory capacity. This imbalance renders adolescents particularly susceptible to emotional dysregulation and stress intolerance, especially in the context of evolving developmental tasks such as autonomy from caregivers, peer affiliation, academic performance, and identity formation.

This presentation examines adolescent distress as a transdiagnostic phenomenon that cuts across traditional diagnostic boundaries. Heightened emotional reactivity and impaired modulation of affect and behavior increase the risk for mental disorders, including internalizing conditions (mood disorders, anxiety disorders, obsessive–compulsive disorder, post-traumatic stress disorder), and externalizing conditions (autism-spectrum disorders, attention-deficit/hyperactivity disorder (ADHD), oppositional defiant and /conduct disorder, cluster B personality disorders, addiction).

Common manifestations of severe emotional distress include depersonalization and derealization experiences, reflecting altered self-perception and stress-related dissociation; non-suicidal self-injurious behaviors (NSSIBs) as maladaptive emotion regulation strategies; and suicidal ideation and attempts, which remain among the leading causes of morbidity and mortality in this age group. Notably, these phenomena frequently signal overwhelmed regulatory systems rather than fixed psychopathology and may fluctuate with environmental stressors, interpersonal conflicts, and developmental transitions.

For clinicians, early detection and structured interventions are critical. Routine screening for distress, depression, behavioral dysregulation, NSSBI, and suicidal ideation in pediatric and mental health settings is recommended, using brief validated tools and direct questioning. A comprehensive diagnostic evaluation should assess comorbid psychosocial stressors (e.g., bullying, trauma), family functioning, psychiatric disorders, and substance use. Evidence-based non-pharmacological interventions remain first-line and include psychoeducation, school-based supports, family-based approaches, cognitive-behavioral therapy, and dialectical behavior therapy for self-harm/emerging borderline personality disorder. Medications may be indicated for underlying disorders such as major depression, anxiety disorders, ADHD, or bipolar disorder, but should be embedded within a multimodal treatment plan and accompanied by careful monitoring of symptom trajectories, safety signals, and treatment adherence.

By integrating developmental neuroscience, clinical phenomenology, and stress-diathesis perspectives, this talk emphasizes the importance of recognizing adolescent distress as a dynamic and potentially reversible state. Understanding the limits of emotional distress tolerance in adolescence has critical implications for early identification, prevention, and intervention strategies that prioritize emotion regulation capacity, contextual stress reduction, and supportive identity development over premature diagnostic labeling.

• Althoff, R. R., Singh, M. K., Stringaris, et al. (2024). Research agenda in childhood impairing emotional outbursts: a report of the AACAP Presidential Taskforce on Emotional Dysregulation. JAACAP Open, 3(1), 147–155.
• Baumel, A., Pawar, A., Kane, J. M., & Correll, C. U. (2016). Digital parent training for children with disruptive behaviors: systematic review and meta-analysis of randomized trials. Journal of Child and Adolescent Psychopharmacology, 26(8), 740–749. doi: 10.1089/cap.2016.0048.
• Becker, M., & Correll, C. U. (2020). Suicidality in childhood and adolescence. Deutsches Ärzteblatt International, 117(15), 261–267. doi: 10.3238/arztebl.2020.0261.
• Knapp, P., Chait, A., Pappadopulos, E., Crystal, S., Jensen, P. S., & T-MAY Steering Group. (2012). Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management. Pediatrics, 129(6), e1562–e1576.
• Leibenluft, E., Allen, <...> & Stringaris, A. (2024). Irritability in youths: a critical integrative review. American Journal of Psychiatry, 181(4), 275–290. doi: 10.1176/appi.ajp.20230256.